Post-marketing phase 4 safety & tolerability study of Breztri aerosphereTM in Indian patients with Chronic Obstructive Pulmonary Disease

Trial Identifier:	D5980L00017
Sponsor:	AstraZeneca
Start Date:	May 2025
Primary Completion Date:	October 2026
Study Completion Date:	December 2026
Condition:	Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.